
Tabby Khan, MD, MPH, senior director of Analytics at Komodo Health, calls for increased lung cancer screening measures and criteria to address underreported, at-risk populations like AAPI women.
Sabrina McCrear is an assistant editor for The American Journal of Managed Care® (AJMC®), which she joined in 2025. She produces written and video content across a range of disease areas and manages social media platforms for The Center for Biosimilars, an AJMC® publication.
Sabrina holds a B.A. in Journalism with a minor in Biology from Howard University in Washington, D.C. You can connect with her on LinkedIn.
Tabby Khan, MD, MPH, senior director of Analytics at Komodo Health, calls for increased lung cancer screening measures and criteria to address underreported, at-risk populations like AAPI women.
Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with a higher risk of developing luminal-like breast cancer subtypes and other subtypes.
The CMS Bundled Payment for Care Improvement (BPCI) Advanced model was successful at reducing spending for outpatient procedures for patients receiving back and neck except spinal fusion treatments or procedures.
Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post menopause, a recent study found.
Prenatal exposure to air pollution was associated with childhood obesity risk in a recent study, highlighting the urgent need for environmental health awareness.
Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, impacting minority communities across the US.
The aim of the study was to not only observe the disparities exacerbated by the COVID-19 pandemic but also to draw attention to the issue to drive real, lasting change.
Prenatal and early-life factors significantly influence childhood obesity trajectories, highlighting the need for early interventions to promote healthy growth.
Obesity was significantly more prevalent in Black and Hispanic children and adolescents compared with their non-Hispanic White peers and was potentially exacerbated by the COVID-19 pandemic, a study found.
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.